Find a Commonwealth Resource
Revefenacin
HealthData.Gov
Updated Jul 6, 2026
About this dataset
YUPELRI (revefenacin) is a prescription inhalation solution containing 175 mcg of revefenacin per 3 mL vial, used as an anticholinergic medication for respiratory conditions. Manufactured by Viatris Specialty LLC, it is administered via nebulizer for maintenance treatment. This information was generated using AI and is provided for informational and research purposes only.
Data and resources (1)
- HTML
Revefenacin
Access the FDA dataset for Revefenacin — ANDA 203308 submitted by Mylan Institutional LLC
Modified Dec 27, 2025